source
- Legend Biotech CEO Ying Huang resigns, interim leader Alan Bash appointedLegend Biotech announced that its chief executive, Ying Huang, Ph.D., stepped down on Friday, with no permanent successor named yet. The board named Alan Bash as interim CEO on July 23, according…
- Almac Clinical Services podcast details end-to-end clinical trial supply chainAlmac Clinical Services released a six-part podcast that walks listeners through the clinical trial supply chain from protocol planning to patient delivery. The series, published by BioPharma Dive’…